ArticleAmerican journal of translational research2018

Tepoxalin a dual 5-LOX-COX inhibitor and erlotinib an EGFR inhibitor halts progression of gastric cancer in tumor xenograft mice.

Xinyang Lu et al.PubMed ↗Full text ↗

No numbers read from the abstract.